Hans Peter Wild - 15 May 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Reporting relationship: 10%+ Owner
Issuer ticker: ADCT
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2025, 15:52:01 UTC
Prior SEC filing: 06 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Dr. Hans-Peter Wild

Key filing fact

Hans Peter Wild filed Form 4 for ADC Therapeutics SA (ADCT) on 19 May 2025.

Key facts

This page summarizes Hans Peter Wild's Form 4 filing for ADC Therapeutics SA (ADCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 15:52.

Change

Previous filing in this sequence was filed on 06 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000905538 Primary reporting owner

WILD HANS PETER

Relationship: 10%+ Owner
Address: NEUGASSE 22, ZUG, SWITZERLAND
Signature: /s/ Dr. Hans-Peter Wild
Signature date: 15 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADCT transaction

Common Shares

Other

Transaction value
Shares: +9,788,944
Change %
Price
Shares after: 9,788,944
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Dr. Hans-Peter Wild ("Dr. Wild") holds a portion of the shares directly and another portion indirectly via HP Wild Holding AG ("HPW Holding") and HPWH TH AG ("HPWH"). The principal business of HPWH is holding investment rights in, directly or indirectly, ADCT. HPW Holding is an intermediary holding company and Dr. Wild is the Chairman of HPW Holding and HPWH. Thomas Pfisterer was a member of the Board of HPWH and held a total of 451,856 shares directly or indirectly in HPWH, but has transferred such ownership by way of an intragroup sale following Thomas Pfisterer stepping down from the Board of HPWH.